- FDA OKs First Immunotherapy Regimen for Extensive Small Cell Lung Cancer – Specialty Pharmacy Times
- The story of GARP: A potential target for cancer immunotherapy – Science Daily
- Immunotherapy Duo Improves Efficacy in Treatment-Resistant Colorectal Cancer – Curetoday.com
- China is reviving a discredited AIDS immunotherapy — for cancer – STAT
- Phase 2 Trial of OncBioMune's Immunotherapy Cancer Vaccine ProscaVax for Prostate Cancer Patients in Active Surveillance Now Open for Enrollment – GlobeNewswire
- The Story of GARP: A Potential Target For Cancer Immunotherapy – R & D Magazine
- Mesothelioma Patient Included in Broader Immunotherapy Study – Mesothelioma.net Blog
